TIM-1 acts a dual-attachment receptor for Ebolavirus by interacting directly with viral GP and the PS on the viral envelope

Abstract

Ebolavirus can cause hemorrhagic fever in humans with a mortality rate of 50%−90%. Currently, no approved vaccines and antiviral therapies are available. Human TIM1 is considered as an attachment factor for EBOV, enhancing viral infection through interaction with PS located on the viral envelope. However, reasons underlying the preferable usage of hTIM-1, but not other PS binding receptors by filovirus, remain unknown. We firstly demonstrated a direct interaction between hTIM-1 and EBOV GP in vitro and determined the crystal structures of the Ig V domains of hTIM-1 and hTIM-4. The binding region in hTIM-1 to EBOV GP was mapped by chimeras and mutation assays, which were designed based on structural analysis. Pseudovirion infection assays performed using hTIM-1 and its homologs as well as point mutants verified the location of the GP binding site and the importance of EBOV GP-hTIM-1 interaction in EBOV cellular entry.

Keywords

Ebolavirus / viral entry / glycoprotein / receptor / interaction

References

[1] Adams PD (2010) PHENIX: a comprehensive python-based system for macromolecular structure solution. Acta Crystallogr Sect D 66(2): 213−221

[2] Angata T, Varki A (2002) Chemical diversity in the sialic acids and related α-keto acids: an evolutionary perspective. Chem Rev 102(2): 439−470

[3] Brindley MA (2007) Ebola virus glycoprotein 1: identification of residues important for binding and postbinding events. J Virol 81(14): 7702−7709

[4] Cao E (2007) T cell immunoglobulin mucin-3 crystal structure reveals a galectin-9-independent ligand-binding surface. Immunity 26(3): 311−321

[5] Côté M (2011) Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. Nature 477(7364): 344−348

[6] DeLano WL (2002) The PyMOL molecular graphics system

[7] Dolnik O, Kolesnikova L, Becker S (2008) Filoviruses: interactions with the host cell. Cell Mol Life Sci 65(5): 756−776

[8] Emsley P, Cowtan K (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr Sect D 60(12): 2126−2132

[9] Feigelstock D, Thompson P, Mattoo P, Zhang Y, Kaplan GG (1998) The human homolog of HAVcr-1 codes for a hepatitis A virus cellular receptor. J Virol 72(8): 6621−6628

[10] Freeman GJ, Casasnovas JM, Umetsu DT, DeKruyff RH (2010) TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity. Immunol Rev 235(1): 172−189

[11] Huang Y-H (2015) CEACAM1 regulates TIM-3-mediated tolerance and exhaustion. Nature 517(7534): 386−390

[12] Hunt CL, Lennemann NJ, Maury W (2012) Filovirus entry: a novelty in the viral fusion world. Viruses 4(2): 258−275

[13] Jemielity S (2013) TIM-family proteins promote infection of multiple enveloped viruses through virion-associated phosphatidylserine. PLoS Pathog 9(3): e1003232

[14] Kelm S, Schauer R (1997) Sialic acids in molecular and cellular interactions. Int Rev Cytol 175: 137−240

[15] Kondratowicz AS (2011) T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus. Proc Natl Acad Sci 108(20): 8426−8431

[16] Kuchroo VK, Umetsu DT, DeKruyff RH, Freeman GJ (2003) The TIM gene family: emerging roles in immunity and disease. Nat Rev Immunol 3(6): 454−462

[17] Kuhn JH (2006) Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire ebolavirus bind a common receptor. J Biol Chem 281(23): 15951−15958

[18] Kuroda M, Fujikura D, Nanbo A, Marz A, Noyori O, Kajihara M, Maruyama J, Yoshida R, Feldmann H, Takada A (2015) The interaction between TIM-1 and NPC1 is important for the cellular entry of Ebola virus. J Virol 89: 6481

[19] Larkin M (2007) Clustal W and Clustal X version 2.0. Bioinformatics 23(21): 2947−2948

[20] Lee JE (2008) Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature 454(7201): 177−182

[21] Li M (2014) TIM-family proteins inhibit HIV-1 release. Proc Natl Acad Sci 111(35): E3699−E3707

[22] Matthews BW (1968) Solvent content of protein crystals. J Molbiol 33(2): 491−497

[23] May A, Robinson R, Vinson M, Crocker P, Jones E (1998) Crystal structure of the N-terminal domain of sialoadhesin in complex with 3′ sialyllactose at 1.85 Å resolution. Mol Cell 1(5): 719−728

[24] McCoy AJ (2007) Phaser crystallographic software. J Appl Crystallogr 40(4): 658−674

[25] Meertens L (2012) The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry. Cell Host & Microbe 12(4): 544−557

[26] Mercer J, Helenius A (2008) Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells. Science 320(5875): 531−535

[27] Moller-Tank S, Kondratowicz AS, Davey RA, Rennert PD, Maury W (2013) Role of the phosphatidylserine receptor TIM-1 in enveloped-virus entry. J Virol 87(15): 8327−8341

[28] Otwinowski Z, Minor W (1997) Processing of X-ray diffraction data. Methods Enzymol 276: 307−326

[29] Powlesland AS (2008) A novel mechanism for LSECtin binding to Ebola virus surface glycoprotein through truncated glycans. J Biol Chem 283(1): 593−602

[30] Rennert PD (2011) Novel roles for TIM-1 in immunity and infection. Immunol Lett 141(1): 28−35

[31] Santiago C (2007a) Structures of T cell immunoglobulin mucin receptors 1 and 2 reveal mechanisms for regulation of immune responses by the TIM receptor family. Immunity 26(3): 299−310

[32] Santiago C (2007b) Structures of T cell immunoglobulin mucin protein 4 show a metal-Ion-dependent ligand binding site where phosphatidylserine binds. Immunity 27(6): 941−951

[33] Schauer R, Kamerling JP (1995) Chemistry, biochemistry and biology of sialic acids. New Compr Biochem 29: 243−402

[34] Silberstein E (2003) Alteration of hepatitis A virus (HAV) particles by a soluble form of HAV cellular receptor 1 containing the immunoglobulin-and mucin-like regions. J Virol 77(16): 8765−8774

[35] Soares MM, King SW, Thorpe PE (2008) Targeting inside-out phosphatidylserine as a therapeutic strategy for viral diseases. Nat Med 14(12): 1357−1362

[36] Takada A (1997) A system for functional analysis of Ebola virus glycoprotein. Proc Natl Acad Sci 94(26): 14764−14769

[37] Wang X (2014) Hepatitis A virus and the origins of picornaviruses. Nature

[38] Wool-Lewis RJ, Bates P (1998) Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines. J Virol 72(4): 3155−3160

[39] Zaccai NR (2003) Structure-guided design of sialic acid-based Siglec inhibitors and crystallographic analysis in complex with sialoadhesin. (Translated from eng). Structure 11(5): 557−567 (in eng)

[40] Zhang W (2003a) Visualization of membrane protein domains by cryo-electron microscopy of dengue virus. Nat Struct Mol Biol 10(11): 907−912

[41] Zhang Y (2003b) Structures of immature flavivirus particles. EMBO J 22(11): 2604−2613

RIGHTS & PERMISSIONS

2014 This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.